GI & Endoscopy

Findlay-based Gastroenterology Associates of Northwest Ohio welcomed Vivian Chidi, MD, to its staff.

Ironwood Pharmaceuticals reported results from its phase IIB trial for IW-3718, its gastroesophageal reflux disease therapy.

On July 13th CMS published its proposed changes to the 2018 fee schedule for sedation during upper and lower endoscopies.

Alexandria Phan, MD, is the medical director of the gastrointestinal center at Southeastern Regional Medical Center in Newnan, Ga., a part of Cancer Treatment Centers of America.

Eugene (Ore.) Gastroenterology Consultants is the largest gastroenterology group south of Portland, Ore.

Here are five updates on GI companies from the past week:

The FDA approved Gilead Sciences' Vosevi as a second line therapy for chronic hepatitis C.

The colorectal cancer treatment market could reach $5.03 billion by 2021, growing at a compound annual growth rate of 2.21 percent from 2016 to 2021, according to Market Data Forecast analysis.

Five years ago, Michael DiMarino, MD, of Woodbury, N.J.-based DiMarino-Kroop-Prieto Gastrointestinal Associates, began using gMed's products to assist with the value process. He reported he has never experienced such a simplified, user-friendly platform.

Paul Craig, MD, is a gastroenterologist at Spokane, Wash.-based Valley Gastroenterology.